Trial description
A Phase II, open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma
Contact name
Dr Fiona Harris
Trial start date
Monday, January 21, 2019
Trial end date
Friday, July 31, 2020
Trial tumour type
Brain and CNS
Show on Radiotherapy